期刊文献+

TIMP-2基因过表达抑制成釉细胞瘤侵袭性生长的实验研究 被引量:1

下载PDF
导出
摘要 目的探讨基质金属蛋白酶组织抑制剂-2(TIMP-2)基因转染体外培养的人成釉细胞瘤(AM)细胞侵袭性生物学行为的改变,进一步研究MMP-2、TIMP-2与AM局部侵袭性的关系。方法 pcDNA3.1(+)/GFP-TIMP-2质粒转染人AM细胞。空白对照组:不加任何处理因素;脂质体对照组:加入4μL Lipo-fectamine 2000和250μL Opti-MEMⅠ混合物;转染阴性载体对照组(P0):转染2μg阴性对照质粒pcDNA3.1(+)/GFP;实验组:分别转染不同浓度的质粒pcDNA3.1(+)/GFP-TIMPI 1μg(P1)、2μg(P2)、3μg(P3)。倒置相差荧光显微镜观察转染情况,流式细胞仪测定转染效率。明胶酶谱法检测基质蛋白酶-2(MMP-2)的活性。逆向明胶酶谱法检测TIMP-2的活性。RT-PCR分析MMP-2以及TIMP-2 mRNA的表达。Western blot分析MMP-2及TIMP-2蛋白的表达情况。三维培养观察分析细胞生长状况。Transwell微侵袭分析。结果与空白对照组比较,不同浓度质粒转染组的MMP-2均有不同程度的抑制,差异有显著性(P<0.05);72 h MMP-2抑制率为54.38%。TIMP-2的活性均有不同程度的增加,差异有统计学意义(P<0.05);72 h的TIMP-2增加率为43.75%。MMP-2蛋白表达水平P2明显低于P1、P3组,差异有统计学意义(P<0.05);与空白对照组比较,转染72 h后,不同质粒组的MMP-2蛋白表达水平的抑制率分别为16.1%、45.3%及39.6%。不同浓度组的TIMP-2蛋白表达水平的增加率分别为26.1%、61.3%及32.6%。在Transwell中培养72 h后,各对照组之间细胞的细胞计数差异无统计学意义(P>0.05);与空白对照组比较,质粒转染组Transwell下室细胞的细胞数明显减少(P<0.05)。两组的相对侵袭抑制率分别为53.7%及46.9%。结论 TIMP-2基因转染AM细胞后,TIMP-2的mR-NA及蛋白表达增加,蛋白活性亦增加;MMP-2 mRNA表达量无明显改变,其蛋白表达量及活性降低。细胞的侵袭性被部分抑制,可能机制是TIMP-2基因过表达使MMP-2活性降低所致。TIMP-2及MMP-2以及两者的关系可能是影响AM局部侵袭性生长的原因之一。
出处 《广东医学》 CAS CSCD 北大核心 2011年第10期1239-1243,共5页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:30471896) 广东省自然科学基金资助项目(编号:10151051501000101) 南方医科大学南方医院院长基金(编号:2009C019)
  • 相关文献

参考文献12

  • 1黄洪章,张磊涛,曾东林,张彬.含绿色荧光蛋白报告基因的TIMP-2真核表达载体的构建及其在人成釉细胞瘤中的表达[J].中华口腔医学杂志,2006,41(12):713-714. 被引量:2
  • 2CHANTRAIN C F,HENRIET P,JODELE S,et al.Mechanisms of pericyte recruitment in tumour angiogenesis:a new role for metalloproteinases[J].Eur J Cancer,2006,42(3):310-318.
  • 3MUNSHI H G,WU Y I,ARIZTIA E V,et al.Calcium regulation of matrix metalloproteinasemediated migration in oral squamous cell carcinoma cells[J].J Biol Chem,2002,277(44):41480-41488.
  • 4MUNSHI H G,WU Y I,MUKHOPADHYAY S,et al.Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2-and p38 MAPK-modulated tissueinhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis[J].J Biol Chem,2004,279(37):39042-39050.
  • 5陶谦,黄洪章.成釉细胞瘤中基质金属蛋白酶MMP-2的表达及意义[J].口腔颌面外科杂志,2000,10(4):325-326. 被引量:9
  • 6张彬,黄洪章,潘朝斌,陶谦.成釉细胞瘤MMP-2、TIMP-2、MT1-MMP mRNA的表达和意义[J].口腔颌面外科杂志,2003,13(1):21-24. 被引量:7
  • 7黄洪章,张彬,陶谦,潘朝斌,魏菁.MMP-2抑制剂对成釉细胞瘤细胞体外侵袭的影响[J].中国口腔颌面外科杂志,2004,2(4):266-269. 被引量:13
  • 8STETLER STEVENSON W G,KRUTZSCH H C,LIOTTA L A,et al.Tissue inhibitor of metalloproteinase (TIMP-2).A new member of the metalloproteinase inhibitor family[J].J Biol chem,1989,164(29):17374-17378.
  • 9HURST D R,LI H,XU X,et al.Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer[J].Biochem Biophys Res Commun,2001,281(1):166-171.
  • 10YOSHIZAKI T,SATO H,Furukawa M.Recent advances in the regulation of matrix metalloproteinase 2 activation:from basic research to clinical implication (Review)[J].Oncol Rep,2002,9(3):607-611.

二级参考文献14

  • 1黄洪章,张彬,陶谦,潘朝斌,魏菁.MMP-2抑制剂对成釉细胞瘤细胞体外侵袭的影响[J].中国口腔颌面外科杂志,2004,2(4):266-269. 被引量:13
  • 2[1]Deshane J, Garner CC, Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 [J]. J Biol Chem,2003, 278(6): 4135-4144.
  • 3[2]Di Nezza LA, Misajon A, Zhang J, et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion[J]. Cancer, 2002, 94(5): 1466-1475.
  • 4[4]Kleiner D, Stetler-Stevenson W. Quantitative zymography: detection of pictogram quantities of gelatinases[J]. Anal Biochem, 1994,218(2): 325-329.
  • 5[5]Saad S, Gottlieb DJ, Bradstock KF, et al. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts[J]. Cancer Res, 2002, 62(1):283-289.
  • 6[6]Sato T, Iwai M, Sakai T, et al. Enhancement of membrane-type1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelationase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts[J]. Br J Cancer, 1999, 80(8): 1137-1143.
  • 7[7]Kubota S, Ito H, Ishibashi Y, Seyama Y. Anti-alpha3 integrin antibody induces the activated form of matrix metalloprotease-2(MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells[J]. Int J Cancer, 1997,70(1): 106-111.
  • 8[8]Deryugina EI, Bourdon MA, Jungwirth K, et al. Functional activation of integrin alphaV beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase[J]. Int J Cancer, 2000,86(1):15-23.
  • 9Stetler-Stevenson WG,Krutzsch HC,Liotta LA.Tissue inhibitor of metalloproteinase (TIMP-2).A new member of the metalloproteinase inhibitor family.J Biol Chem,1989,264:17374-17378.
  • 10Miyake H,Hara I,Gohji K,et al.Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regμlates their metastatic potential.Clin Cancer Res,1999,5:2824-2829.

共引文献21

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部